Literature DB >> 3887075

[Therapeutic pancreatic duct occlusion in chronic pancreatitis: clinical, exocrine and endocrine consequences in a 12 month follow-up study].

M U Schneider, G Lux, C Gebhardt, R Meister, J Pichl, G Heptner, H Knorr, T Rödle, S Domschke, W Domschke.   

Abstract

Therapeutic pancreatic duct occlusion (PDO) is applied to preserve endocrine pancreatic function by atrophizing and thus eliminating chronically inflamed exocrine pancreatic parenchyma. So far, efficient and lasting elimination of exocrine parenchyma is brought about only by intraoperative PDO upon partial duodenopancreatectomy. While partial duodenopancreatectomy itself reduces endocrine pancreatic function by about 40%, intraoperative PDO does not further impair endocrine function. Endocrine function is not affected at all by endoscopic PDO, which has to be improved, however, concerning its eliminatory effect on exocrine pancreatic parenchyma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887075     DOI: 10.1007/bf01261289

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  38 in total

1.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

2.  [Enzymatic determination of glucose and fructose simultaneously].

Authors:  F H SCHMIDT
Journal:  Klin Wochenschr       Date:  1961-12-01

3.  [Blocking of pancreatic exocrine function in the treatment of chronic pancreatitis (author's transl)].

Authors:  E Hoffmann; J Usmiani; C Gebhardt
Journal:  Dtsch Med Wochenschr       Date:  1977-03-18       Impact factor: 0.628

4.  Beta-cytotrophic effects of glucose, glucagon, and tolbutamide in man.

Authors:  W G Ryan; A F Nibbe; T B Schwartz
Journal:  Lancet       Date:  1967-06-10       Impact factor: 79.321

5.  Insulin secretion after tolbutamide and after secretin in patients with pancreatic diseases.

Authors:  T Deckert; K Kolendorf; I Persson; H Worning
Journal:  Acta Med Scand       Date:  1972-11

6.  [Chronic pancreatitis. Problems of indication for surgery and contribution to the spontaneous process of chronic recurrent pancreatitis].

Authors:  R Ammann
Journal:  Dtsch Med Wochenschr       Date:  1970-01-02       Impact factor: 0.628

7.  Chronic pancreatitis--results in 116 consecutive, partial duodenopancreatectomies combined with pancreatic duct occlusion.

Authors:  F P Gall; C Gebhardt; H Zirngibl
Journal:  Hepatogastroenterology       Date:  1982-06

8.  Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects.

Authors:  M Perley; D M Kipnis
Journal:  Diabetes       Date:  1966-12       Impact factor: 9.461

9.  [Late results after surgery in chronic pancreatitis (author's transl)].

Authors:  J Rosenberger; W Stock; P Altmann; H Pichlmaier
Journal:  Leber Magen Darm       Date:  1980-02

10.  [Partial duodenopancreatectomy and intraoperative occlusion of the pancreatic duct: preliminary results].

Authors:  K W Steegmüller; H M Märklin; R Fischer
Journal:  Z Gastroenterol       Date:  1982-10       Impact factor: 2.000

View more
  5 in total

1.  [Pancreatic duct occlusion from the clinical viewpoint: exocrine and endocrine consequences].

Authors:  M U Schneider
Journal:  Langenbecks Arch Chir       Date:  1989

2.  [Insulin reserve and morphology of the tail of the pancreas following resection of the head of the pancreas using various surgical methods].

Authors:  D Grossner; H von Kroge; M Berkhoff; R Klapdor; G Klöppel
Journal:  Langenbecks Arch Chir       Date:  1989

3.  [Chronic pancreatitis. Surgical therapy by resection procedures].

Authors:  F P Gall
Journal:  Langenbecks Arch Chir       Date:  1987

4.  Granulomatous pancreatitis--granulomas in chronic pancreatitis.

Authors:  J Stürmer; V Becker
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Subtotal resection of the head of the pancreas combined with ductal obliteration of the distal pancreas in chronic pancreatitis.

Authors:  R P Kerremans; F M Penninckx; J De Groote; J Fevery
Journal:  Ann Surg       Date:  1987-03       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.